Bios Capital Management, LP Portfolio Holdings

Bios Capital Management, LP has filed its 13F form on May 14, 2025 for Q1 2025 where it was disclosed a total value porftolio of $79.2 Billion distributed in 9 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Actuate Therapeutics Inc with a value of $67B, Lantern Pharma Inc. with a value of $4.28B, Rein Therapeutics Inc with a value of $2.99B, Cognition Therapeutics Inc with a value of $2.52B, and In8 Bio, Inc. with a value of $1.43B.

Examining the 13F form we can see an decrease of $14.9B in the current position value, from $94.1B to 79.2B.

Bios Capital Management, LP is based out at Fort Worth, TX

Below you can find more details about Bios Capital Management, LP portfolio as well as his latest detailed transactions.